NIH-funded research R01 grant

Using heart rate variability to improve brain stimulation treatments

Official title: HRV-guided tDCS: Integrating a biomarker for clinical utility

Funded at New York University School of Medicine · NIH-11161506 · Data updated 2026-11-12

This study is looking at how to make brain stimulation treatments more effective for people with depression by using heart rate measurements to tailor the sessions just for you, so you can even do them at home!

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 5, 2024
Project endApril 30, 2028
Funding year2025
Award (this year)$690,895
NIH project number5R01EB035129-02
Project IDNIH-11161506 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who experience neuropsychiatric symptoms, particularly those related to depression.

Less likely to help

Patients with conditions that do not respond to neuropsychiatric treatments or those under 21 years old may not benefit from this research.

What this research studies

This research investigates how to enhance the effectiveness of transcranial direct current stimulation (tDCS), a noninvasive brain stimulation technique, by using heart rate variability (HRV) as a biomarker. The goal is to personalize and optimize treatment sessions based on individual responses, which may lead to better outcomes for patients with neuropsychiatric symptoms like depression. The approach includes integrating HRV monitoring into a telehealth platform, allowing for home-based administration of tDCS. By measuring HRV, researchers aim to determine the best timing and dosage for each patient, potentially improving treatment efficacy.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized treatments for neuropsychiatric conditions, improving patient outcomes.

How similar studies have gone: Previous research has shown promise in using biomarkers to guide neurostimulation treatments, suggesting that this approach could be effective.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Pilloni, Giuseppina — New York University School of Medicine
  • Study coordinator: Pilloni, Giuseppina

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.